By Professor Susan Jane Connor

Journal articles

Koo JH; Jalaludin BB; Kneebone AB; Connor SJ; Leong R, 2008, 'Improved survival in young women with colorectal cancer', American Journal of Gastroenterology, 103, pp. 1488 - 1495, http://dx.doi.org/10.1111/j.1572-0241.2007.01779.x

Chin BW; Grimm MC; Connor SJ; Leong RW, 2006, 'Managing inflammatory bowel disease', Medicine Today, 7, pp. 14 - 23

Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm M, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420

Connor SJ; Paraskevopoulos N; Newman R, 2004, 'CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease (vol 53, pg 1287, 2004)', GUT, 53, pp. 1722 - 1722, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224407200042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm M, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294

Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990

Connor SJ; Grimm MC, 2001, 'Heparin as an anti-inflammatory agent: It's no GAG to forget about chemokines [3]', Gut, 48, pp. 738, http://dx.doi.org/10.1136/gut.48.5.738

Amansec SG; Connor SJ; Cardillo R; Cuan N; Grimm MC; Conway P, 2001, 'AMELIORATION OF MURINE TNBS COLITIS USING PREBIOTICS', Journal of Gastroenterology and Hepatology, 16, pp. 6 - 6, http://dx.doi.org/10.1111/j.1440-1746.2001.ca01-6.x

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, 120, pp. A82 - A82, http://dx.doi.org/10.1016/s0016-5085(08)80404-0

Connor ; Seow ; Ngu ; Katelaris , 1999, 'The effect of dosing with omeprazole on the accuracy of the ¹³C‐urea breath test in Helicobacter pylori‐infected subjects', Alimentary Pharmacology & Therapeutics, 13, pp. 1287 - 1293, http://dx.doi.org/10.1046/j.1365-2036.1999.00601.x

Connor SJ; Ngu MC; Katelaris PH, 1999, 'The impact of short-term ranitidine use on the precision of the 13C-urea breath test in subjects infected with Helicobacter pylori', European Journal of Gastroenterology & Hepatology, 11, pp. 1135 - 1138, http://dx.doi.org/10.1097/00042737-199910000-00010

Goldblum JR; Hart WR, 1998, 'Perianal Paget's Disease', The American Journal of Surgical Pathology, 22, pp. 170 - 179, http://dx.doi.org/10.1097/00000478-199802000-00004

Norrie MWA; Chapman G; Connor SJ, 1997, 'A case of upper gastrointestinal bleeding secondary to a bread bag clip', Australian and New Zealand Journal of Medicine, 27, pp. 75, http://dx.doi.org/10.1111/j.1445-5994.1997.tb00918.x

Khin-Maung-U ; Tin-Aye ; Ku-Tin-Myint ; Tin-Oo ; Myo-Khin ; Thackway SA; Connor SJ; Bolin TD; Duncombe VM, 1992, 'In vitro hydrogen production by enteric bacteria cultured from children with small bowel bacterial overgrowth', Journal of Pediatric Gastroenterology and Nutrition, 14, pp. 192 - 197, http://dx.doi.org/10.1097/00005176-199202000-00013

Khin‐Maung‐U ; Tin‐Aye ; Ku‐Tin‐Myint ; Tin‐Oo ; Myo‐Khin ; Thackway SA; Connor SJ; Bolin TD; Duncombe VM, 1992, 'In Vitro Hydrogen Production by Enteric Bacteria Cultured from Children with Small Bowel Bacterial Overgrowth', Journal of Pediatric Gastroenterology and Nutrition, 14, pp. 192 - 197, http://dx.doi.org/10.1002/j.1536-4801.1992.tb10524.x

KENDALL JJ; POWELL EN; CONNOR SJ; BRIGHT TJ; ZASTROW CE, 1985, 'EFFECTS OF TURBIDITY ON CALCIFICATION RATE, PROTEIN-CONCENTRATION AND THE FREE AMINO-ACID POOL OF THE CORAL ACROPORA-CERVICORNIS', MARINE BIOLOGY, 87, pp. 33 - 46, http://dx.doi.org/10.1007/BF00397003

POWELL EN; KENDALL JJ; CONNOR SJ; ZASTROW CE; BRIGHT TJ, 1984, 'EFFECT OF 8 OUTER CONTINENTAL-SHELF DRILLING MUDS ON THE CALCIFICATION RATE AND FREE AMINO-ACID POOL OF THE CORAL ACROPORA-CERVICORNIS', BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 33, pp. 362 - 372, http://dx.doi.org/10.1007/BF01625556

POWELL EN; CONNOR SJ; KENDALL JJ; ZASTROW CE; BRIGHT TJ, 1984, 'RECOVERY BY THE CORAL ACROPORA-CERVICORNIS AFTER DRILLING MUD EXPOSURE - THE FREE AMINO-ACID POOL', ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 13, pp. 243 - 258, http://dx.doi.org/10.1007/BF01055883

KENDALL JJ; POWELL EN; CONNOR SJ; BRIGHT TJ; ZASTROW CE, 1984, 'THE IMPORTANCE OF MONITORING METABOLIC RECOVERY IN THE CORAL ACROPORA-CERVICORNIS AFTER SHORT-TERM EXPOSURE TO DRILLING MUDS - CALCIFICATION RATE AND PROTEIN-CONCENTRATION', CORAL REEFS, 2, pp. 215 - 225

KENDALL JJ; POWELL EN; CONNOR SJ; BRIGHT TJ, 1983, 'THE EFFECTS OF DRILLING-FLUIDS (MUDS) AND TURBIDITY ON THE GROWTH AND METABOLIC STATE OF THE CORAL ACROPORA-CERVICORNIS, WITH COMMENTS ON METHODS OF NORMALIZATION FOR CORAL DATA', BULLETIN OF MARINE SCIENCE, 33, pp. 336 - 352

Conference Papers

Hanna L; Joshi S; Capstick R; Ramsden J; Lawrence S; Robinson D; Alexander J; Sahnan K; Warusavitarne J; Connor S; Lung P; Tozer P; Hart A, 2026, 'O26 Developing a treat-to-target framework for perianal crohn’s disease: an international initiative from the TOpClass consortium', BMJ, pp. a16.2 - a1a17, presented at Oral Abstracts, http://dx.doi.org/10.1136/gutjnl-2026-bsg.25

Liu S; Wu R; Wilson B; Caquilpan V; Connor SJ; Andrews JM, 2025, 'Colectomy trends in ulcerative colitis amidst an expanding therapeutic landscape: Insights from a clinical care registry', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 107 - 107

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong RW, 2025, 'Complete disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: A post-hoc analysis from the VIEWS randomised controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 92 - 92

Wu R; Caquilpan V; Wilson W; Andrews JM; Connor SJ, 2025, 'Divided by distance: Insights into regional disparities in inflammatory bowel disease care across Australia from the Crohn's Colitis Cure Data Insights Program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 108 - 110

Seng C; Wu R; Su WK; Wilson W; Connor SJ; Andrews JM; Walker G, 2025, 'Older-onset inflammatory bowel disease: How are we managing this specialty cohort in Australasia? Crohn's Colitis Cure Data Insights Program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 112 - 113

Wu R; Su WK; Wilson W; Connor SJ; Andrews JM, 2025, 'Real-world patterns in the route of administration of infliximab and vedolizumab for inflammatory bowel disease: Clinician inertia?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 117 - 118

Wu R; Su WK; Wilson W; Deschenes R; Connor SJ; Andrews JM, 2025, 'Real-world persistence of biologic therapies in Crohn's disease: Insights from the Crohn's Colitis Care registry and comparison with the Persistence Australia National Inflammatory Bowel Disease Cohort (PANIC) registry', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 89 - 90

Wu R; Wilson W; Caquilpan V; Connor SJ; Andrews JM, 2025, 'Real-world trends in infliximab use and route switching in inflammatory bowel disease in Australia from 2021 to 2024: Insights from Crohn's Colitis Cure Data Insights Program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 113 - 114

Wu R; Petch B; Deschenes R; Connor SJ; Andrews JM, 2025, 'The likely return on investment from broad implementation of an inflammatory bowel disease-specific clinical quality registry: Towards sustainable inflammatory bowel disease care', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 118 - 119

Su WK; Connor SJ; Andrews JM; Wilson W, 2025, 'The short Crohn's Disease Activity Index (CDAI) is a reliable measure of clinical disease activity and practical alternative to the full CDAI and Harvey-Bradshaw Index in real-world inflammatory bowel disease practice', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 85 - 86

Pipicella JL; Gu B; Palmer LJ; Connor SJ; Wilson WE; Andrews JM, 2024, 'ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN CROHN'S DISEASE: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1444 - S1445, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Gu B; Pipicella JL; Palmer LJ; Connor SJ; Wilson WE; Andrews JM, 2024, 'ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN ULCERATIVE COLITIS: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1444 - S1444, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Alshiwanna B; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1135 - S1135, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Barnett MI; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1134 - S1135, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

McNamara J; Alshiwanna B; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1135 - S1135, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

De Gregorio M; Winata LS-H; Hartley I; Behrenbruch CC; Connor SJ; D'Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJ; Schulberg JD; Srinivasan A; Sutherland T; Woods R; Wright EK; Connell W; Thompson A; Ding NS, 2024, 'IMPROVED CLINICAL AND RADIOLOGIC HEALING OF CROHN'S PERIANAL FISTULAS USING A NOVEL COORDINATED CARE MODEL OPTIMISING MEDICAL AND SURGICAL TREATMENTS: A PROSPECTIVE REAL-WORLD OBSERVATIONAL STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1126 - S1127, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S854 - S855, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Pipicella JL; McNamara J; Wilson WE; Lynch KD; Walker GJ; Begun J; Lawrance IC; Ghaly S; Radford-Smith GL; Williams A-J; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1456 - S1457, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Khoo E; Amiss A; Ding NS; Bryant RV; Mohsen W; Connor SJ; Leong R; Croft A; Lynch KD; Sparrow M; De Cruz P; An Y-K; Holtmann GJ; Begun J, 2024, 'TOFACITINIB DEMONSTRATES PRELIMINARY EFFICACY IN INDUCTION OF REMISSION IN CHRONIC POUCHITIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S216 - S217, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S839 - S839, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Taxonera C; Ha C; Fortes MDP; Gardiner S; Mundayat R; Ghosh S; Connor SJ, 2023, 'Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. 678 - 679

McNamara J; Pipicella JL; Connor SJ; Andrews JM, 2023, 'IDDF2023-ABS-0141 The evolving role of technology in delivering patient-centric care in inflammatory bowel disease – an australasian experience using crohn’s colitis care e-health patient portal', BMJ, pp. a203.1 - a2a203, presented at Clinical Gastroenterology, http://dx.doi.org/10.1136/gutjnl-2023-iddf.193

McNamara J; Andrews JM; Connor SJ; Pipicella JL; Wilson W, 2023, 'IDDF2023-ABS-0146 Disease and treatment factors influencing outcomes in fistulising crohn’s disease', BMJ, pp. a203.2 - a2a204, presented at Clinical Gastroenterology, http://dx.doi.org/10.1136/gutjnl-2023-iddf.194

Pipicella JL; Karimi N; Wang G; Willmann L; Descallar J; O’Connor K; Connor S; Leung Y; Huang V; Williams A-J, 2021, 'IDDF2021-ABS-0062 A novel decision aid improves knowledge and quality of pregnancy-related decision-making in IBD', in Gut, BMJ, pp. a108 - a108, presented at Clinical Gastroenterology, http://dx.doi.org/10.1136/gutjnl-2021-iddf.126

Dunning A; Sechi A; Williams A; Connor S; Ng W; Kuzet G; Cabaero A, 2019, 'Use of a novel tool to identify nutritional risk in an inflammatory bowel disease outpatient service: Liverpool IBD-Nutrition Screen', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 200 - 200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Armuzzi A; Kayhan C; Panaccione R; Watanabe K; Molander P; Rubin DT; Peyrin-Biroulet L; Melmed G; Connor S; Colombel J-F; Dubinsky M, 2019, 'P005 DELAY IN DIAGNOSIS OF ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', in Inflammatory Bowel Diseases, Oxford University Press (OUP), pp. s4 - s4, http://dx.doi.org/10.1093/ibd/izy393.008

Schreiber S; Panaccione R; Kayhan C; Lopez-Sanroman A; Peyrin-Biroulet L; Armuzzi A; Dubinsky M; Melmed G; Rubin M; Connor S; Keefer L; Rubin DT, 2019, 'P023 PATIENT AND HEALTHCARE PROFESSIONAL VIEWS ON EMOTIONAL HEALTH AND INTIMACY IN ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', in Inflammatory Bowel Diseases, Oxford University Press (OUP), pp. s12 - s12, http://dx.doi.org/10.1093/ibd/izy393.027

Lord A; Mortlock S; Montgomery G; Simms LA; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'Genetically distinct signatures of mild and severe ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 103 - 104, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Little RD; Chu IE; van der Zanden EP; Flanagan E; Bell SJ; Sparrow MP; Shelton E; Connor SJ; Roblin X; Ward MG, 2018, 'Is there a difference in adalimumab drug levels according to pen versus syringe use: An international, multicenter retrospective analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 102 - 102, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor S; Sechi A; Witcombe D; Fox H, 2018, 'YUlcerative Colitis (UC) Narrative Study Australian data: A survey to compare patient and physician perspectives on communication and management of UC', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 105 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page